JournalsHub
.online
Find My Journal
LJ

Lingjing Jiang

Johnson & Johnson (United States) US

ORCID 0000-0001-8706-2850
66
Publications
33,023
Citations
29
H-Index
37
i10-Index
6.4
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

913b THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

J. Allegretti, L. Peyrin-Biroulet, B. Feagan, B. Bressler, G. Lichtenstein - Gastroenterology, 2023
Cited by 5 Semantic Scholar

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer OA

Jinbo Lin, Lei Zhang, Dong-wen Wu, Z. Xi, Xue-jun Wang - World Journal of Gastroenterology, 2017
Cited by 30 Semantic Scholar

Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence – A retrospective single-center study OA

Yanhong Deng, Yue Cai, Jiayu Lin, Ling-Ya Jiang, Huabin Hu - Gastroenterology Report, 2015
Cited by 7 Semantic Scholar

Research Topics

Gut microbiota and health (28) Metabolomics and Mass Spectrometry Studies (18) Diet and metabolism studies (10) Gene expression and cancer classification (8) Inflammatory Bowel Disease (4)

Affiliations

Ningbo University
CN 2023 - 2023
Zhejiang Sci-Tech University
CN 2024 - 2024
Johnson & Johnson (United States)
US 2026 - 2026
UC San Diego Health System
US 2021 - 2021
University of California System
US 2017 - 2017

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now